Acorda Therapeutics Inc's Customers Performance

Name: Acorda Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ACORQ

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ACORQ's Source of Revenues		During the corresponding time, Acorda Therapeutics Inc saw a revenue deteriorated by -8.85 % year on year, sequentially revenue fell by -46.59 %. While revenue at the Acorda Therapeutics Inc 's corporate clients • List of ACORQ Customers

for the same period Acorda Therapeutics Inc revnue deteriorated by -8.85 % year on year, sequentially revenue fell by -46.59 %.

• List of ACORQ Customers

Acorda Therapeutics Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Acorda Therapeutics Inc's Comment on Sales, Marketing and Customers

The company commercializes pharmaceutical products including Ampyra, Inbrija, and Fampyra. It utilizes third-party manufacturers for production and works with distributors and partners outside the United States to market these products. The company faces competition from generic versions of Ampyra in the U.S. and Fampyra in Germany, as well as reimbursement challenges with third-party payers, including governmental agencies. Following the termination of its collaboration agreement with Biogen, the company seeks to establish additional collaborations and distribution arrangements. Its market segments include the U.S. and international pharmaceutical markets, with specific activity in Germany for Fampyra.

Acorda Therapeutics Inc’s Comment on Sales, Marketing and Customers

ACORQ's Stock Performance relative to it's Customers

ACORQ's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Acorda Therapeutics Inc	0.00	99.94	-62.49	102
SUBTOTAL	0.00	0.00	0.00	-

Sources: Acorda Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Acorda Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Acorda Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.